Doctors tried to lower $148K cancer drug cost; makers triple price of pill

Doctors tried to lower $148K cancer drug cost; makers triple price of pill

  • April 21, 2018
Table of Contents

Doctors tried to lower $148K cancer drug cost; makers triple price of pill

Imbruvica’s makers, Janssen and Pharmacyclics, have now gotten approval to sell four different tablets of varying strengths: 140mg, 280mg, 420mg, and 560mg. But the new pills will all be the same price—around $400 each—even the 140mg dose pill. The makers willstop selling the old, cheaper 140mg pill within three months, according to a report by the Washington Post.

Source: arstechnica.com

Share :
comments powered by Disqus

Related Posts

An Augmented Reality Microscope for Cancer Detection

An Augmented Reality Microscope for Cancer Detection

Applications of deep learning to medical disciplines including ophthalmology, dermatology, radiology, and pathology have recently shown great promise to increase both the accuracy and availability of high-quality healthcare to patients around the world. At Google, we have also published results showing that a convolutional neural network is able to detect breast cancer metastases in lymph nodes at a level of accuracy comparable to a trained pathologist. However, because direct tissue visualization using a compound light microscope remains the predominant means by which a pathologist diagnoses illness, a critical barrier to the widespread adoption of deep learning in pathology is the dependence on having a digital representation of the microscopic tissue.

Read More